Story perspectives
Europe Approves 100% Effective HIV Injection Yeytuo
8/26/2025
31 7
1 of 1
Story summary
- The European Commission approved lenacapavir, a biannual HIV prevention injection, based on EMA's recommendation.
- Branded as Yeytuo, the drug demonstrated 100% effectiveness in clinical trials, targeting increasing HIV cases in Europe.
- Gilead intends to pursue approvals in various countries and provide generics in 120 low-income nations.
- Availability concerns persist due to decreased health funding in the U.S.
